Cardiovascular Division, Washington University, St. Louis, MO, USA.
NMR Biomed. 2012 Feb;25(2):279-85. doi: 10.1002/nbm.1746. Epub 2011 Jul 12.
PARACEST (PARAmagnetic Chemical Exchange Saturation Transfer) agents offer the ability to generate "contrast on demand", negating the need to image before contrast agent injection. Perfluorocarbon (PFC) nanoparticles can deliver very large payloads of PARACEST agents, lowering the effective detection limit for molecular imaging of sparse biomarkers. Also, the PFC core provides a quantitative (19)F signal for measuring particle binding with high signal intensity and no background signal. (19)F quantization coupled with mathematical modeling of the PARACEST signal showed that incorporating PARACEST chelates onto the nanoparticle surface reduces the bound water lifetime and diminishes the available contrast to noise ratio compared to the parent small molecule PARACEST chelate. PARACEST nanoparticles were targeted to fibrin, an early biomarker for atherosclerotic plaque rupture, and bound to the surface of in vitro clots, yielding a detection limit of 2.30 nM at 11.7T. When the particles bind to a target surface, the image contrast is higher than predicted from phantom experiments, perhaps due to improved water exchange kinetics. We demonstrated that PARACEST PFC nanoparticles can provide two unique signatures, (19)F and PARACEST, for quantitative targeted molecular imaging of fibrin.
PARACEST(顺磁化学交换饱和转移)试剂具有按需产生“对比”的能力,从而无需在注射对比剂之前进行成像。全氟碳(PFC)纳米颗粒可以递送非常大剂量的 PARACEST 试剂,从而降低了稀疏生物标志物分子成像的有效检测极限。此外,PFC 核还提供了定量的 19F 信号,用于测量具有高信号强度和无背景信号的颗粒结合。19F 量化结合 PARACEST 信号的数学模型表明,将 PARACEST 螯合物结合到纳米颗粒表面会降低结合水的寿命,并降低与母体小分子 PARACEST 螯合物相比的可用对比噪声比。PARACEST 纳米颗粒被靶向到纤维蛋白,这是动脉粥样硬化斑块破裂的早期生物标志物,并结合到体外血栓的表面,在 11.7T 时检测限为 2.30 nM。当颗粒与目标表面结合时,图像对比度高于来自体模实验的预测,这可能是由于水交换动力学得到了改善。我们证明了 PARACEST PFC 纳米颗粒可以为纤维蛋白的定量靶向分子成像提供两个独特的特征,即 19F 和 PARACEST。